Tackling osteoarthritis during COVID-19 pandemic.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 32988837.
- Also identified by DOI 10.1136/annrheumdis-2020-218372.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this opinion article, we would like to draw attention to the fact that COVID-19 has a significant impact not only on immune-mediated arthritis but also on osteoarthritis (OA), the most common rheumatic disease. We suggest herein strategies for pain relief and symptom prevention in patients with OA during COVID-19 pandemic.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- COVID-19
- Exercise Therapy
- Glucocorticoids
- Osteoarthritis